These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 18180312

  • 21. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.
    Nakamura Y, Son Y, Kohno Y, Shimono D, Kuwamura N, Koshiyama H, Sasano H, Matsuda T.
    Endocrine; 2001 Jun; 15(1):57-61. PubMed ID: 11572327
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cushing's syndrome variants secondary to aberrant hormone receptors.
    Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J.
    Trends Endocrinol Metab; 2004 Oct; 15(8):375-82. PubMed ID: 15380809
    [Abstract] [Full Text] [Related]

  • 25. Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors.
    Christopoulos S, Bourdeau I, Lacroix A.
    Horm Res; 2005 Oct; 64(3):119-31. PubMed ID: 16215323
    [Abstract] [Full Text] [Related]

  • 26. ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase.
    Hofland J, Hofland LJ, van Koetsveld PM, Steenbergen J, de Herder WW, van Eijck CH, de Krijger RR, van Nederveen FH, van Aken MO, de Groot JW, Links TP, de Jong FH, Feelders RA.
    Orphanet J Rare Dis; 2013 Sep 13; 8():142. PubMed ID: 24034279
    [Abstract] [Full Text] [Related]

  • 27. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia.
    Daidoh H, Morita H, Hanafusa J, Mune T, Murase H, Sato M, Shibata T, Suwa T, Ishizuka T, Yasuda K.
    Clin Endocrinol (Oxf); 1998 Sep 13; 49(3):403-9. PubMed ID: 9861334
    [Abstract] [Full Text] [Related]

  • 28. A possible association between aldosterone response to vasopressin and circadian change of aldosterone in the patients with aldosterone-producing adenoma.
    Suzuki S, Uchida D, Koide H, Suyama K, Shibata T, Yoshida T, Tanaka T, Noguchi Y, Saito Y, Tatsuno I.
    Peptides; 2008 Dec 13; 29(12):2225-31. PubMed ID: 18838094
    [Abstract] [Full Text] [Related]

  • 29. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators.
    Bourdeau I, Antonini SR, Lacroix A, Kirschner LS, Matyakhina L, Lorang D, Libutti SK, Stratakis CA.
    Oncogene; 2004 Feb 26; 23(8):1575-85. PubMed ID: 14767469
    [Abstract] [Full Text] [Related]

  • 30. Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s).
    Suzuki S, Uchida D, Koide H, Tanaka T, Noguchi Y, Saito Y, Tatsuno I.
    Peptides; 2008 Oct 26; 29(10):1767-72. PubMed ID: 18620013
    [Abstract] [Full Text] [Related]

  • 31. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia.
    Louiset E, Duparc C, Young J, Renouf S, Tetsi Nomigni M, Boutelet I, Libé R, Bram Z, Groussin L, Caron P, Tabarin A, Grunenberger F, Christin-Maitre S, Bertagna X, Kuhn JM, Anouar Y, Bertherat J, Lefebvre H.
    N Engl J Med; 2013 Nov 28; 369(22):2115-25. PubMed ID: 24283225
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL, Stoev S, Manning M, Derick S, Pena A, Mimoun MB, Guillon G.
    J Med Chem; 2004 Apr 22; 47(9):2375-88. PubMed ID: 15084136
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction.
    Lacroix A, Bourdeau I, Lampron A, Mazzuco TL, Tremblay J, Hamet P.
    Clin Endocrinol (Oxf); 2010 Jul 22; 73(1):1-15. PubMed ID: 19719763
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.